Evelynne Fulda

December 13, 2021

Prevalence and Correlates of Electrocardiographic Abnormalities in Adults with HIV: Insights from the REPRIEVE Trial

Abstract Background People with HIV (PWH) are at increased risk for cardiovasvular disease (CVD) and sudden cardiac death. Prior work has suggested an association between HIV […]
December 13, 2021

COVID-19 Vaccination Rates in a Global HIV Cohort

Abstract Little is known regarding COVID-19 vaccination rates in people with HIV (PWH), a vulnerable population with significant morbidity from COVID-19. We assessed COVID-19 vaccination rates […]
December 13, 2021

Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus

Abstract Background Emerging data demonstrate that the use of integrase inhibitor (INSTI)-based antiretroviral treatment (ART) is associated with increased weight, but the cardiometabolic health consequences of […]
December 2, 2021

Coronary Plaque in People with Well-Controlled HIV and Low ASCVD Risk

The REPRIEVE study finds that many younger, asymptomatic adults with HIV have levels of plaque that persist despite low traditional risk of ASCVD. Caitlan Rossi, MedPage […]
October 29, 2021

NIH Statement on World AIDS Day 2020

In his #WorldAIDSDay statement, Dr. Fauci highlights how far we have come, how far we have yet to go, and acknowledges the important work of the […]
October 1, 2021

People With HIV Have High Levels of Inflammation and Coronary Plaque

White men and smokers are more likely to have arterial plaque despite low cardiovascular risk scores. Heather Boerner | POZ Read the full article here.
October 1, 2021

ACTG Announces Publication Of REPRIEVE Sub-Study In JAMA Network Open, Providing Insights Into Cardiovascular Disease Risk Among People Living With HIV

Nearly half of the participants (49%) had plaque in their arteries. ACTG Read the full article here.
October 1, 2021

HIV and Coronary Artery Plaque

Researchers ID condition with potential CVD implications. Randy YoungMGH News and Public Affairs Read the full article from HMS here.
July 7, 2021

Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial

Abstract Background In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and HIV-related factors may contribute to future CV events in persons with HIV […]